BLZ945
Catalog No. A15540
BLZ945是有效的选择性CSF-1R激酶抑制剂。它减弱了TAM的周转率,同时增加了浸润宫颈癌和乳腺癌的CD8+ T细胞的数量。
Catalog Num | A15540 |
---|---|
M. Wt | 398.4 |
Formula | C20H22N4O3S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 953769-46-5 |
Synonyms | BLZ 945, BLZ-945 |
SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)NC4CCCCC4O |
BLZ945是有效的选择性CSF-1R激酶抑制剂。它减弱了TAM的周转率,同时增加了浸润宫颈癌和乳腺癌的CD8+ T细胞的数量。
Targets
CSF-1R | ||||
1 nM |
In vitro (25°C) | DMSO | 77 mg/mL (193.23 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 3 mg/mL | ||
In vivo | 4% DMSO+30% PEG 300+ddH2O | 2.3 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.1 mL | 125.5 mL | 251 mL |
0.5 mM | 5.02 mL | 25.1 mL | 50.2 mL |
1 mM | 2.51 mL | 12.55 mL | 25.1 mL |
5 mM | 0.5 mL | 2.51 mL | 5.02 mL |
*The above data is based on the productmolecular weight 398.4. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.